What do you get when you mix contrast delivery with computer technology? Dr. Dominik Fleischmann, director of CT at Stanford Hospital and Clinics kicks off a session at the International Society for Computed Tomography conference starting May 18 on contrast medium delivery and image enhancement. He will focus on how power injectors are starting to act as computers.
What do you get when you mix contrast delivery with computer technology? Dr. Dominik Fleischmann, director of CT at Stanford Hospital and Clinics kicks off a session at the International Society for Computed Tomography conference starting May 18 on contrast medium delivery and image enhancement. He will focus on how power injectors are starting to act as computers.
Fleischmann examines the ways power injectors are also computers and what that means for the radiology community. He will also discuss ways to track data that can be applied to contrast injection such as their use for radiofrequency identification technology.
Sandra S. Halliburton, Ph.D., a cardiac imaging scientist at the Cleveland Clinic poses a question in her presentation, “Contrast volumes for short scan time coronary CTA: how low can we go?” Recent changes in multidetector CT (MDCT) technology allow for extremely short scan times for coronary imaging, and shorter acquisition times permit lower contrast volumes. Thus the question: What is the optimal amount of contrast for enhancement of the coronary arteries during fast MDCT scans? She’ll answer that during her talk.
A well-known risk when it comes to contrast is the possibility of contrast-induced nephropathy (CIN). Dr. Steven D. Weisbord, from the renal section at the VA Pittsburgh Healthcare System and the renal-electrolyte division at the University of Pittsburgh, will describe which patients who undergo CT scans are at the highest risk for CIN. He will also discuss which patients are at high risk following CT and how to determine risk prior to the scan. He’ll list who he thinks should be screened for CIN and how best to estimate renal function.
Dr. Myron Pozniak, a professor of radiology, and chief of the abdominal CT section at the University of Wisconsin in Madison, and a colleague, will present data on contrast-induced acute kidney injury, formerly known as acute renal failure. They will describe how often it occurs and also the conditions that lead to it.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.